Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04524208
Title A Trial of Cabozantinib in Patients With Advanced, Low Proliferative NEN G3 (CABONEN)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Karsten Gavenis
Indications

neuroendocrine tumor

Therapies

Cabozantinib

Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.